We are working towards ending
untreatable painful conditions such as:


Neuropathic Back Pain

Trigeminal Neuralgia


Allodynia and more

Yes, we stop neuropathic pain!


Allodynic Therapeutics is a private pharmaceutical startup company based in Miami. Allodynic Therapeutics’ investigational lead research product is potentially useful for the treatment of neuropathic pain conditions, such as chronic neuropathic back pain, trigeminal neuralgia, complex regional pain syndrome (CRPS), postherpetic neuralgia, fibromyalgia, vulvodynia, migraines, and others.

Allodynic Therapeutics is currently undertaking a clinical trial for the treatment of trigeminal neuralgia using its innovative oral investigational product.

About The Innate Immune System and Pain

Chronic neurological pain is often caused by neural inflammation. This inflammation occurs when the innate immune system releases a cascade of inflammatory mediators. Allodynic Therapeutics’ investigational product works by blocking the innate immune system receptors which trigger the inflammatory cascades.

About Trigeminal Neuralgia

Trigeminal neuralgia is a neuropathic pain condition which occurs in the branches of the trigeminal nerve. It is described as the most excruciating pain known to humanity. While there is no definitive known cause for trigeminal neuralgia, Allodynic Therapeutics believes that many cases of idiopathic trigeminal neuralgia are caused by inflammation of the trigeminal nerve, which is caused by activation of certain innate immune system receptors.